Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
This study is ongoing, but not recruiting participants.
Study NCT00940524
Information provided by Memorial Sloan-Kettering Cancer Center
First Received on July 14, 2009.
Last Updated on January 9, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
